-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

731. Autologous Transplantation: Clinical and Epidemiological: Poster II

Symposia: Autologous Transplantation: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 10, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Nico Gagelmann1*, Laurent Garderet, MD, PhD2*, Simona Iacobelli, PhD3*, Linda Koster4*, Alessandra Carotti5*, Stefan Schönland, MD6*, Piero Galieni, MD7*, Michael Daskalakis, MD8*, Wilfried Roeloffzen, MD, PhD9*, Hannah Hunter, MB, FRCPath, MRCP10*, Michel A. Duchosal, MD11, Stig Lenhoff, MD12*, Mutlu Arat13, Gerald G. Wulf, MD14*, Simon Bolam15*, Domenico Pastore, MD16*, Tobias Gedde-Dahl, MD17*, Deborah Susan Richardson, MD, FRCP, FRCPath, MA, MBBChir18, Stephan Mielke, MD19, Kavita Raj, MD, PhD20, Joanna Drozd-Sokolowska, MD, PhD21*, Patrick John Hayden, MD22 and Donal P McLornan, MD, PhD23*

1Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
2Hôpital la pitié salpetriere, Paris, FRA
3University of Rome Tor Vergata (Dept. of Biology), Rome, ITA
4EBMT Leiden Study Unit, Leiden, Netherlands
5Perugia University, Perugia, PG, ITA
6Department of Internal Medicine V, Division of Hematology/Oncology/Rheumatology, Heidelberg University Hospital, Heidelberg, Germany
7UOC Ematologia Ospedale Mazzoni, Ascoli Piceno, Italy
8University Hospital Bern, Inselspital, Bern, Switzerland
9University Medical Center Groningen, Groningen, Netherlands
10Derriford Hospital, Plymouth, GBR
11Ctr. Hospitalier Univ. Vaudois (CHUV), Lausanne, Switzerland
12Skanes University Hospital, Lund, Sweden
13İstanbul Florence Nightingale Hospital, Hematology Department, İstanbul, Turkey
14Universitaetsklinikum Goettingen, Goettingen, Germany
15Taunton and Somerset NHS Foundation Trust, Taunton, GBR
16Haematology, Ospedale A. Perrino, Brindisi, Italy, Brindisi, Italy
17Oslo University Hospital, Rikshospitalet, Clinic for Cancer Medicine, Hematology Department, Section for Stem Cell Transplantation, Oslo, Norway
18University Hospitals Southampton, Southampton, GBR
19Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Institute & University Hospital, Stockholm, Stockholms Laen, Sweden
20University College London Hospitals NHS Trust, London, United Kingdom
21Central Clinical Hospital, The Medical University of Warsaw, Warsaw, Poland
22Department of Haematology, Trinity College Dublin, St. James’s Hospital, Dublin, Ireland
23Department of Haematology, University College London Hospitals NHS Trust, London, ENG, United Kingdom

María de Lourdes Pastelín-Martínez, MD1,2*, Moisés Manuel Gallardo-Pérez, MD, MSc3,4*, Andres Gomez-De Leon, MD5, Juan Carlos Olivares-Gazca, MD3,6*, Edgar Jared Hernández-Flores, MD2,7*, Daniela Sánchez-Bonilla, MD2,7*, Merittzel Abigail Montes-Robles, MD1,2*, Max Robles-Nasta, MD2*, Guillermo Ocaña-Ramm, MD2,7*, Silvia Soto-Olvera, BSc3,8*, David Gomez-Almaguer, MD9, Guillermo José Ruiz-Delgado, MD3,10 and Guillermo José Ruiz-Arguelles, FRCP3,11

1Facultad de Medicina, Universidad Anáhuac Puebla, Puebla, PU, Mexico
2Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, PU, Mexico
3Universidad Popular Autónoma del Estado de Puebla, Puebla, PU, Mexico
4Investigación Clínica, Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, MEX
5Servicio de Hematología, Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr. José Eleuterio Gonzalez", Monterrey, Mexico
6Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, MEX
7Facultad de Medicina, Universidad Popular Autónoma del Estado de Puebla, Puebla, PU, Mexico
8Laboratorios Ruiz, SYNLAB, Puebla, PU, Mexico
9Universidad Autonoma De Nuevo Leon, Hospital Universitario, Monterrey, Nuevo León, MEX
10Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, Mexico
11Centro De Hematologia Medicina Interna, Puebla, Pue, Mexico

Samer Al Hadidi, MD, MSc1, Obada Ababneh2*, Carson W Ercanbrack3*, Carolina Schinke, MD1, Sharmilan Thanendrarajan, MD1*, Clyde Bailey, BS4*, Robert Smith3*, Susan Panozzo3*, Guido Tricot, MD5*, Daisy V. Alapat, MD6, John D Shaughnessy, Jr, PhD7*, Fenghuang Zhan, MD, PhD1, Bart Barlogie, MD, PhD8*, Maurizio Zangari, MD1 and Frits van Rhee, MD, PhD1

1Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR
2University of Jordan, Irbid, Jordan
3The University of Arkansas for Medical Sciences, Little Rock
4Myeloma Center, Winthrop P. Rockefeller Institute, University of Arkansas for Medical Sciences, Little Rock, AR
5Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas For Medical Sciences, Little Rock, AR
6Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR
7Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR
8Myeloma Center, Winthrop P. Rockefeller Cancer Insitute, University of Arkansas for Medical Sciences, Little Rock, AR

Robert Puckrin, MD1, Colin Stewart, MD2, Carolyn Owen, MD3, Lesley E. Street, MD2*, Sarah Perry, MD2*, Peter Duggan, MD2, Mona Shafey, MD2, Neil Chua, MD4* and Douglas A. Stewart, MD2*

1Tom Baker Cancer Centre and University of Calgary, Calgary, AB, Canada
2Tom Baker Cancer Centre and University of Calgary, Calgary, Canada
3Tom Baker Cancer Centre, Calgary, AB, Canada
4Cross Cancer Institute and University of Alberta, Edmonton, Canada

Erin A. Dean, MD1, Arkaprava Roy2*, Rick Y. Lin, MD3, Raad Z. Gharaibeh1*, Derek M. Li2*, Josee Gauthier2*, Christian Jobin2*, Zeina A. Al-Mansour, MD4 and John R. Wingard, MD5

1University of Florida, Gainesville, FL
2University of Florida, Gainesville
3Department of Medicine, University of Florida, Gainesville, FL
4Department of Medicine/Division of Hematology Oncology, University of Florida, Gainesville, FL
5University of Florida Division of Hematology/Oncology, Gainesville, FL

Shaoxuan Hu1*, Linjun Zhao2*, Weiping Liu3*, Wenrong Huang4, Shunan Qi5*, Xiaopei Wang3*, Yuqin Song, MD6, Yexiong Li5* and Jun Zhu, PhD7

1Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (ministry of Educati, Beijing, China
2Department of Lymphoma, Peking University International Hospital, Beijing, China
3Department of Lymphoma, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China
4Lymphoma & Plasma Cell Disease Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing,China, Beijing, China
5Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China
6Department of Lymphoma, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, BEIJING, China
7Department of Lymphoma, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, Beijing, China

Jorge Arturo Arturo Hurtado Martinez, MD1*, Jay R. Hydren, PhD1*, Patricia Alejandra Flores Pérez, MD1*, Mason S. Barnes1*, Felipe Flores Quiroz, MD1*, Nathan Sweeney, PhD2, Karla Mariana Castro Bórquez, MD1*, Andrea Isabel Robles Espinoza, MD, MBA1* and Jennifer M. Ahlstrom, BA1*

1HealthTree Foundation, Lehi, UT
2Tempus, Chicago, IL

Colin Stewart, MD1*, Carolyn Owen, MD2, Neil Chua, MD3*, Anthea Peters, MD3, Mona Shafey, MD1, Douglas A. Stewart, MD1* and Robert Puckrin, MD4

1Tom Baker Cancer Centre and University of Calgary, Calgary, Canada
2Tom Baker Cancer Centre, Calgary, AB, Canada
3Cross Cancer Institute and University of Alberta, Edmonton, Canada
4Tom Baker Cancer Centre and University of Calgary, Calgary, AB, Canada

Aakanksha Singh, MD1*, Reema Singh, M.Sc.1*, Rohan Halder, MD, MBBS1*, Karuna Jha, MD1*, Tribikram Panda, MD1*, Amir Khan Maroof2*, Niharika Bhatia, M.Sc.1*, Rayaz Ahmed, MD3, Dinesh Bhurani, MD, DM, FRCPA1* and Narendra Agrawal, MD, DM1*

1HEMATOLOGY, RAJIV GANDHI CANCER INSTITUTE & RESEARCH CENTRE, NEW DELHI, India
2Department of Community Medicine, University College of Medical Sciences,, Delhi, India
3HEMATOLOGY, MAX SUPERSPECIALITY HOSPITAL, DELHI, India

Jing Yuan Tan, MBBS1*, Victor Ling Wei Teik2*, Cindy Krisnadi1*, Lawrence Cheng Kiat Ng1,3*, Melinda Si Yun Tan1,3*, Nicholas Francis Grigoropoulos1,3*, Shin Yeu Ong, MD1,3*, Chandramouli Nagarajan, MD, MBBS, FRCP, FRCPath1,3*, Jeffrey Kim Siang Quek1*, Hein Than, MD, FRCPath, MRCP3,4, Joanne Shu Xian Lee, MBBS (UK), MRCP (UK), FRCPath2*, Esther Hian Li Chan, MBBS, MRCP, FRCPath2*, Lip Kun Tan2*, William Ying Khee Hwang, MBBS3,4, Yeow Tee Goh, MBBS1,3, Yeh Ching Linn1,3*, Liang Piu Koh2*, Aloysius Yew Leng Ho1,3, Francesca Lorraine Wei Inng Lim1,3*, Michelle Limei Poon2* and Yunxin Chen1,3*

1Department of Hematology, Singapore General Hospital, Singapore, Singapore
2Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
3National Cancer Centre Singapore, Singapore, Singapore
4Department of Haematology, Singapore General Hospital, Singapore, Singapore

Yige Shen1*, Zhong Zheng2*, Mengmeng Ji3*, Wei Tang4* and Wei Li Zhao, MD5

1National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
2Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, shanghai, China
3Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Nati, Shanghai, CHN
4Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, CHN
5Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

Eleanor Taranto, MD1, Wei-Ting Hwang, PhD2*, Maria Alfaro2*, Annika S Surapaneni3*, Sarvarinder Kaur Gill4*, Tatyana Feldman, MD4, Michael P Randall, MD5, Michael A Spinner, MD5, Fateeha Furqan, MBBS6, Nirav N. Shah, MD6, Yazeed Samara, MD7*, Matthew G. Mei, MD7, Alex F. Herrera, MD7, Alison Moskowitz, MD8, Gunjan L. Shah8 and Jakub Svoboda, MD3

1Lymphoma Program, Abramson Cancer Center, The University of Pennsylvania, philadelphia, PA
2Department of Biostatistics, Epidemiology, and Informatics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
3Lymphoma Program, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA
4John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
5Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA
6Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI
7City of Hope National Medical Center, Duarte, CA
8Memorial Sloan Kettering Cancer Center, New York, NY

*signifies non-member of ASH